Visage Imaging and Definiens Announce Partnership

Share Name	Share Symbol	Market	Type
Premd	AMEX:PME	AMEX	Ordinary Share

Premd (AMEX:PME)
Historical Stock Chart

From Jul 2019 to Jul 2024

Companies to Provide Advanced Oncology Imaging Solutions for the Clinical and Preclinical Domain MUNICH, Germany, PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PRNewswire/ -- Definiens, the number one Enterprise Image Intelligence® company, and Visage Imaging® Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX:PME) announced today that they have entered into a partnership to jointly develop and market advanced oncology solutions for the clinical and preclinical imaging domain. The partnership enables Definiens to utilize the Visage® CS enterprise visualization application in its forthcoming Definiens LymphExpert(TM) Version 2.0. By quantifying lymph nodes not only according to RECIST and WHO guidelines but also by their volume, the new integrated solution allows for efficient lesion analysis including automated quantification of lymph nodes. Visage's technology provides Definiens LymphExpert(TM) Version 2.0 with a thin client based interface for full local and remote access as well as universal connectivity to image acquisition devices and image archives. "Visage® CS provides an efficient workflow across different oncology applications. The platform's intuitive user interface concept allowed us to seamlessly pair it with the Definiens LymphExpert(TM), resulting in an extremely fast and easy-to-use solution," said Frank-P. Klein, Vice President, Medical Imaging at Definiens. "As a result, radiologists can now easily compare changes in lymph node size over time and thus derive additional information about the efficacy of a given therapy." "Definiens Lymph Expert allows for new levels of automation and efficiency in lymph node analysis. Adding this technology to the Visage platform is one important step in responding to the trend towards more quantitative and standardized diagnostics," says Dr. Malte Westerhoff, CTO Visage Imaging. "We are excited about this cooperation," said David Chambers, CEO of Visage Imaging. "Definiens is one of the leading innovators in the area of image understanding and quantification. Their technology combined with our Thin Client based enterprise visualization platform will allow us to bring very attractive solutions to the clinical and pre-clinical imaging markets." About Visage Imaging Visage Imaging is a global leading provider of scalable enterprise visualization, RIS and PACS solutions for clinical and preclinical imaging. Targeted at hospitals and imaging centers of any size, the Visage products offer blazingly fast access to thin slice data anytime, anywhere, combined with a bi-directional RIS integration for a perfect workflow and a comprehensive set of clinical applications for all 2D, 3D and 4D interpretation and reporting, post-processing and image review tasks within and beyond radiology. Visage visualization and PACS solutions are registered as medical devices in Europe, Canada and Australia, and have received FDA clearance. http://www.visageimaging.com/ Visage, Visage Imaging, and Visioneering Science for Life are registered trademarks of Pro Medicus Limited. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders. Definiens in Medical Imaging By automating image analysis, Definiens supports healthcare providers in analyzing and interpreting vast numbers of digital images accurately and consistently. Definiens improves the analysis of tissue samples and non-invasive imaging, enabling translational medicine - from early diagnosis to personalized treatment. About Definiens Definiens is the number one Enterprise Image Intelligence® company for analyzing and interpreting images on every scale, from microscopic cell structures to satellite images. The Definiens Cognition Network Technology®, developed by Nobel Laureate Prof. Gerd Binnig and his team, is an advanced and robust context-based technology designed to fulfill the image analysis requirements of the Medical, Life Science and Earth Science markets. The technology is modeled on the powerful human cognitive perception processes to extract intelligence from images. Definiens provides organizations with faster image analysis results, allowing deeper insights enabling better business decisions. The company is headquartered in Munich, Germany and has offices in the United States. Further information is available at http://www.definiens.com/ Definiens, Definiens Cellenger, Definiens Cognition Network Technology, Definiens eCognition, Enterprise Image Intelligence and Understanding Images are trademarks or registered trademarks of Definiens. DATASOURCE: Visage Imaging Inc. CONTACT: Diane M. Clifford, Director, Global Marketing, Visage Imaging, Inc./ Pro Medicus Limited, +1-978-662-5401, ; or Eva Tietz, Manager, Corporate Communications, Definiens, Web Site: http://www.visageimaging.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

PME Premd